We further conducted experiments and verified that exogenously overexpression of COL11A1 promotes breast cancer cells resistant to tamoxifen, while COL11A1 knockdown restores sensitivity of TamR cells to tamoxifen both in vitro and in vivo. This evidence concerns the gene COL11A1 and breast carcinoma.